Premenopausal: Clinical Trials

10 trials for Premenopausal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 active not recruiting, 2 recruiting, 1 terminated. 5 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Active not recruiting 2, Completed 1, Recruiting 1, Terminated 1
Phase 12Completed 2

Follow Premenopausal: new trials by email Literature Review of Premenopausal trials Research Report on Premenopausal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxytocin in Postmenopausal Women
Repeated assessments - Postmenopausal, Premenopausal
RecruitingUniversity Hospital, Basel, Switzerland302026-08-202026-08-24
The Influence of Plan B® on Cardiovascular Health.
Plan B (Levonorgestrel), Placebo (gelatin capsule) - Female, Premenopausal
Not applicableRecruitingMcMaster University402026-07-222026-10-14
Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)
Micronized progesterone (oral capsules), placebo capsule - Healthy Volunteers, Female
Phase 1CompletedMcMaster University202026-01-012026-06-17
Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
Gonadotropin-releasing hormone agonist, Chemotherapy - Gonadotropin Releasing Hormone Agonists, Ovarian Function
Not applicableCompletedHelwan University1002022-06-012026-08-11
Comprehensive Lifestyle Change To Prevent Breast Cancer
Cancer Prevention, Questionnaire Administration - Premenopausal
Not applicableActive not recruitingM.D. Anderson Cancer Center602019-04-042026-08-11
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
Adenosine, Magnetic Resonance Imaging, Regadenoson - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
CompletedWake Forest University Health Sciences252018-06-212026-01-29
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
Laboratory Biomarker Analysis, Oophorectomy, Quality-of-Life Assessment - Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation
Not applicableActive not recruitingM.D. Anderson Cancer Center3742016-05-022026-07-15
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Questionnaire Administration - Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Gastrointestinal Stromal Tumor
WithdrawnUniversity of Southern California2016-03-012024-03-18
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
Everolimus, Laboratory Biomarker Analysis, Letrozole - Advanced Malignant Solid Neoplasm, Estrogen Receptor Positive
Phase 1CompletedM.D. Anderson Cancer Center372014-07-172020-12-19
Validation of [18F]FES for Imaging of Brain Estrogen Receptors
FES-PET - Psychiatric/Mood Disorder | Patient, Estrogen Receptor Levels
Not applicableTerminatedUniversity Medical Center Groningen32013-11-012024-04-18

Narrower conditions

Breast Neoplasms (2)  ·  Anxiety Disorders (1)  ·  Depression (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Hereditary Breast and Ovarian Cancer Syndrome (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Venous Thrombosis (1)

Broader conditions

Neoplasms (4)  ·  Breast Diseases (3)  ·  Neoplasms by Site (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Adnexal Diseases (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Bone Marrow Diseases (1)  ·  Breast Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Interventions

Adenosine (1)  ·  Drug Therapy (1)  ·  Everolimus (1)  ·  Gelatin (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  High-Energy Shock Waves (1)  ·  Letrozole (1)  ·  Levonorgestrel (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Ogivri (1)  ·  Ovariectomy (1)  ·  PF-05280014 (1)  ·  Progesterone (1)  ·  Salpingectomy (1)  ·  Salpingo-oophorectomy (1)

Sponsors

M.D. Anderson Cancer Center (3)  ·  McMaster University (2)  ·  Helwan University (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University Medical Center Groningen (1)  ·  University of Southern California (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (5)  ·  Canada (2)  ·  Egypt (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Andor Glaudemans, MD (1)  ·  Emily Douglas (1)  ·  Filip Janku (1)  ·  Irene Woo (1)  ·  Lorenzo Cohen (1)  ·  Mark Crowther, MD, MSc, LLM, FRCPC, FRSC (1)  ·  Maureen J MacDonald, PhD (1)  ·  Mirjam Christ-Crain, Prof. Dr. med. (1)  ·  Roni N Wilke, MD (1)

Results publications

PMID 33115815, PMID 42412428

NIH funding

P30CA012197 (1), P30CA014089 (1), P30CA016672 (1)